The globally active specialty chemicals group ALTANA achieved stable sales and earnings development in the first half of 2025 despite increasingly challenging market conditions. At 1,624 million euros, sales were 1 percent below the strong prior-year figure. ALTANA increased its earnings before interest, taxes, depreciation and amortization (EBITDA) by 1 percent to 290 million euros in the first six months of the year. In the Americas, operating sales also increased by 1 percent, while nominal sales declined by 2 percent. ACTEGA's sales of 257 million euros were 4 percent (3 percent in operational terms) below the previous year.